Literature DB >> 6776182

Effect of metergoline on serum prolactin stimulated by TRH.

F Iannotta1, G Gadaleta, C Pollini, M P Vettaro.   

Abstract

The PRL response to TRH was evaluated before and after acute administration of metergoline, an antiserotonin drug, in healthy subjects. The drug was given to two groups of 6 subjects each, at the dose of 4 and 8 mg respectively, either po or by im route. Metergoline significantly inhibited the PRL response to TRH; no significant difference was found between the two doses and the administration routes. Although these findings suggest that the drug may directly inhibit lactotropic cells, an action of metergoline on central nervous system to stimulate PIF or to inhibit PRF release cannot be ruled out, and might as well explain the inhibition of the PRL response to TRH.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776182     DOI: 10.1007/BF03348280

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.

Authors:  D M Lawson; R R Gala
Journal:  Endocrinology       Date:  1975-02       Impact factor: 4.736

2.  Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors.

Authors:  K Fuxe; L Agnati; B Everitt
Journal:  Neurosci Lett       Date:  1975-11       Impact factor: 3.046

3.  Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents.

Authors:  C Mawson; H Whittington
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

4.  Effect of anterior pituitary perfusion and intraventricular injection of catecholamines on prolactin release.

Authors:  I A Kamberi; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1971-04       Impact factor: 4.736

5.  Multifactorial regulation of prolactin secretion.

Authors:  H A Zacur; G V Foster; J E Tyson
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

6.  Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.

Authors:  C Ferrari; R Caldara; P Rampini; P Telloli; M Romussi; A Bertazzoni; G Polloni; A Mattei; P G Crosignani
Journal:  Metabolism       Date:  1978-10       Impact factor: 8.694

7.  Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion.

Authors:  C Ferrari; R Caldara; M Romussi; P Rampini; P Telloli; S Zaatar; G Curtarelli
Journal:  Neuroendocrinology       Date:  1978       Impact factor: 4.914

8.  Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man.

Authors:  C Ferrari; A Paracchi; M Rondena; P Beck-Peccoz; G Faglia
Journal:  Clin Endocrinol (Oxf)       Date:  1976-09       Impact factor: 3.478

9.  Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex.

Authors:  B S Sastry; J W Phillis
Journal:  Can J Physiol Pharmacol       Date:  1977-02       Impact factor: 2.273

10.  Stimulation of human prolactin secretion by intravenous infusion of L-tryptophan.

Authors:  J H MacIndoe; R W Turkington
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.